The landscape of diabetes management is rapidly shifting, with the emergence of dual GIP and GLP-1 receptor agonists. Both The Tirzepatide and Retatrutide represent significant advancements; The Tirzepatide https://tirzepatide-40mg336451.wikistatement.com/user